Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Algernon Pharmaceuticals (AGNPF)

OTHER OTC:AGNPF

AGNPF

Algernon Pharmaceuticals

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding AGNPF?

Track your performance easily

Link Broker

Algernon Pharmaceuticals (AGNPF) Income Statement

71 Followers

Algernon Pharmaceuticals Income Statement

Last quarter (Q3 2024), Algernon Pharmaceuticals's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, Algernon Pharmaceuticals's net income was C$1.44M. See Algernon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Aug 23	Aug 22	Aug 21	Aug 20	Aug 19
Total Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	C$ 2.98M	C$ 5.24M	C$ 6.02M	C$ 8.05M	C$ 8.66M	C$ 1.91M
Operating Income	C$ -2.98M	C$ -5.24M	C$ -6.02M	C$ -8.05M	C$ -8.66M	C$ -1.91M
Net Non Operating Interest Income Expense	C$ 1.87K	C$ 2.10K	C$ 2.08K	C$ -11.93K	C$ -35.08K	C$ -6.72K
Other Income Expense	C$ -3.45M	C$ -1.54M	C$ -36.48K	C$ 305.12K	C$ 87.77K	C$ 11.62K
Pretax Income	C$ -2.61M	C$ -6.78M	C$ -6.05M	C$ -7.73M	C$ -8.54M	C$ -1.90M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -2.61M	C$ -6.78M	C$ -6.05M	C$ -7.73M	C$ -8.54M	C$ -1.90M
Basic EPS	C$ 0.47	C$ 0.45	C$ 0.87	C$ -1.24	C$ -2.50	C$ -0.01
Diluted EPS	C$ 0.48	C$ 0.45	C$ 0.87	C$ -1.24	C$ -2.50	C$ -0.01
Basic Average Shares	C$ 51.22M	C$ 15.15M	C$ 6.95M	C$ 6.23M	C$ 3.52M	C$ 178.67M
Diluted Average Shares	C$ 51.73M	C$ 15.15M	C$ 6.95M	C$ 6.23M	C$ 3.52M	C$ 178.67M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 985.85K	-	C$ 6.02M	C$ -8.05M	C$ -8.66M	C$ -1.91M
Net Income From Continuing And Discontinued Operation	C$ -2.61M	C$ -6.78M	C$ -6.05M	C$ -7.73M	C$ -8.54M	C$ -1.90M
Normalized Income	C$ -2.06M	C$ -3.44M	C$ -4.41M	C$ -5.68M	C$ -6.36M	C$ -1.40M
Interest Expense	-	-	-	-	-	-
EBIT	C$ -2.61M	C$ -6.78M	C$ -6.05M	C$ -7.73M	C$ -8.54M	C$ -1.90M
EBITDA	C$ -2.59M	C$ -6.73M	C$ -6.02M	C$ -7.73M	C$ -8.54M	C$ -1.87M

Currency in CAD

Algernon Pharmaceuticals Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing